Global ATMP Service Providers Market

Report ID : 1228 | Published : 2022-06-01 | Pages: 150 | Format: PDF/EXCEL

The ATMP Service Providers market size was accounted at USD 13.85 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2022 to 2030. Advanced Therapy Medicinal Products (ATMPs) are therapies for human consumption with an active therapeutic substance that may be based on the technology to modify a patient's genome, recombinant nucleic acids or genes, engineered tissue and substantially manipulated cells or cells intended for a different essential function in the patient versus the donor. They offer groundbreaking new opportunities to treat life-threatening diseases where one or limited doses have a curative effect. In the case of gene-based ATMPs, recombinant genes are generated in the lab by combining several DNA from different sources to treat genetic abnormalities, cancer, or long-term diseases. In cell-based therapies, cells are modified to change their biological properties or cells or tissues that are not meant for the same vital roles in the body. They are capable of curing, diagnosing, and preventing diseases. Tissue-engineered therapies of ATMP have cells or tissues that have been modified to be used to repair, regenerate or replace human tissue. ATMP services include analysis of active therapeutic substances, documentation, standards and regulations in GMP, and logistics like storage and transportation.

Increasing demand for personalized medication pushes the technology towards advancements in biological therapeutics, leading to innovative Advanced Therapy Medicinal Products, which is the crucial factor for ATMP service providers' market growth. Extensive research activities, rising approvals for new drug products, stakeholders' investments in clinical trials and Large pipeline products will boost the service providers' market. The COVID-19 outbreak has adversely affected the overall medical industry, but the pandemic enabled the operations and development of advanced therapeutics. In Feb 2022, Takara Bio, Inc expanded the GMP facility to accommodate a variety of modalities and strengthen the supply chain. The facility's expansion, which went into operation in 2020, increased production capacity.

Lack of production capabilities and cost of services regarding ATMP production are significant factors affecting the progress of the ATMP services providers market. The availability of a significant number of FDA-approved advanced therapy medicinal products in the United States has gained a substantial share of revenue in the North America region.

Global ATMP Service Providers market is segmented into by type services and by applications. Type of services comprises analytics, quality, CMO, logistics. The subsegment analytics covers Microbiology, Endotoxin, PCR, Flow Cytometry, ELISA, Container Closure, Sterilty, and Pre-clinical. Quality subegment has documentation, QMS and regulations. Whereas, CMO includes HQ/GMP plasmid DNA, MSC manufacture, Pluripotent stem cells. In logistics, storage, stability and transport are subdivisions. CMO will contribute the largest share of the revenue in the coming years in the ATMP service providers market. Secondly, the segmentation by application contains GTMP(Gene Therapy Medicinal Products), sCTMP(somatic Cells Therapy Medicinal Products) and TEP(Tissue Engineered Products).

Significant market players are Takara Bio, NorthX Biologics, Cellco Labs, AWA, ClinStorage, Key2Complience, Nordic BioAnalysis, YSDS, Truly Labs, ABC Labs, Mikrolabs, NDA group, Propharma group, Celonic, Bio Elpida, CGT Catapult, Rentschler Biopharma SE, AGC Biologics, Catalent, WuXi Advanced Therapies, BlueReg, Minaris Regenerative Medicine, Patheon, Bio-Techne Corporation, bioMérieux SA, Catalent, Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Intertek Group plc, Lonza Group AG, Merck KGaA, Sartorius AG, SGS S.A., Sistemic Scotland Limited, Thermo Fisher Scientific Inc., Vigene Biosciences, Inc., WuXi AppTec and others.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global ATMP Service Providers Market Snapshot

Chapter 4. Global ATMP Service Providers Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Type of Service, Estimates & Trend Analysis

5.1. By Type of Service, & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type of Service:

5.2.1. Analytics/CRO

5.2.1.1. Microbioilogy

5.2.1.2. Endotoxin

5.2.1.3. PCR

5.2.1.4. Flow Cytometry

5.2.1.5. ELISA

5.2.1.6. Container Closure

5.2.1.7. Sterility

5.2.1.8. Pre-clinical

5.2.2. Quality

5.2.2.1. Documentation

5.2.2.2. QMS

5.2.2.3. Regulations

5.2.3. CMO

5.2.3.1. HQ/GMP Plasmid DNA

5.2.3.2. MSC Manufacture

5.2.3.3. Pluripotent Stem Cells

5.2.4. Logistics

5.2.4.1. Storage

5.2.4.2. Stability

5.2.4.3. Transport

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:

6.2.1. GTMP

6.2.2. sCTMP

6.2.3. TEP

Chapter 7. ATMP Service Providers Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America ATMP Service Providers Market revenue (US$ Million) estimates and forecasts By Type of Service, 2019-2030

7.1.2. North America ATMP Service Providers Market revenue (US$ Million) estimates and forecasts By Application, 2019-2030

7.1.3. North America ATMP Service Providers Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

7.2. Europe

7.2.1. Europe ATMP Service Providers Market revenue (US$ Million) By Type of Service, 2019-2030

7.2.2. Europe ATMP Service Providers Market revenue (US$ Million) By Application, 2019-2030

7.2.3. Europe ATMP Service Providers Market revenue (US$ Million) by country, 2019-2030

7.3. Asia Pacific

7.3.1. Asia Pacific ATMP Service Providers Market revenue (US$ Million) By Type of Service, 2019-2030

7.3.2. Asia Pacific ATMP Service Providers Market revenue (US$ Million) By Application, 2019-2030

7.3.3. Asia Pacific ATMP Service Providers Market revenue (US$ Million) by country, 2019-2030

7.4. Latin America

7.4.1. Latin America ATMP Service Providers Market revenue (US$ Million) By Type of Service, (US$ Million) 2019-2030

7.4.2. Latin America ATMP Service Providers Market revenue (US$ Million) By Application, (US$ Million) 2019-2030

7.4.3. Latin America ATMP Service Providers Market revenue (US$ Million) by country, 2019-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa ATMP Service Providers Market revenue (US$ Million) By Type of Service, (US$ Million) 2019-2030

7.5.2. Middle East & Africa ATMP Service Providers Market revenue (US$ Million) By Application, (US$ Million) 2019-2030

7.5.3. Middle East & Africa ATMP Service Providers Market revenue (US$ Million) by country, 2019-2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Takara Bio

8.2.2. NorthX Biologics

8.2.3. Cellco Labs

8.2.4. AWA

8.2.5. ClinStorage

8.2.6. Key2Complience

8.2.7. Nordic BioAnalysis

8.2.8. YSDS

8.2.9. Truly Labs

8.2.10. ABC Labs

8.2.11. Mikrolabs

8.2.12. NDA group

8.2.13. Propharma group

8.2.14. Celonic

8.2.15. Bio Elpida

8.2.16. CGT Catapult

8.2.17. Rentschler Biopharma SE

8.2.18. AGC Biologics

8.2.19. WuXi Advanced Therapies

8.2.20. BlueReg, Minaris Regenerative Medicine

8.2.21. Patheon

8.2.22. Bio-Techne Corporation

8.2.23. bioMérieux SA

8.2.24. Catalent, Inc.

8.2.25. Charles River Laboratories International Inc.,

8.2.26. Eurofins Scientific SE

8.2.27. F. Hoffmann-La Roche Ltd

8.2.28. Intertek Group plc

8.2.29. Lonza Group AG

8.2.30. Merck KGaA

8.2.31. Sartorius AG

8.2.32. SGS S.A.

8.2.33. Sistemic Scotland Limited

8.2.34. Thermo Fisher Scientific Inc.

8.2.35. Vigene Biosciences, Inc.

8.2.36. WuXi AppTec

8.2.37. Other Prominent Players

Global ATMP Service Providers Market, by Type of Service, 2022-2030 (Value US$ Mn)

  • Analytics/CRO
    • Microbioilogy
    • Endotoxin
    • PCR
    • Flow Cytometry
    • ELISA
    • Container Closure
    • Sterility
    • Pre-clinical
  • Quality
    • Documentation
    • QMS
    • Regulations
  • CMO
    • HQ/GMP Plasmid DNA
    • MSC Manufacture
    • Pluripotent Stem Cells
  • Logistics
    • Storage
    • Stability
    • Transport

Global ATMP Service Providers Market, by Application, 2022-2030 (Value US$ Mn)

  • GTMP
  • sCTMP
  • TEP

 

Global ATMP Service Providers Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa ATMP Service Providers Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients